Home
Radiology Guides Anatomy Physio & Path Medicine Physics Contact
DIABETES MELLITUS-GLYCEMIC TREATMENT GOALS

Endocrinology

DIABETES MELLITUS-GLYCEMIC TREATMENT GOALS

1. Target levels: FPG < 110 mg/dL; 2-hr post-prandial glucose < 140 mg/dL; HbA1c <= 6.5%

2. Target HbA1c has been loosened to < 8% in the following groups: severe hypoglycemia, decraesed life-expectancy, advanced complications, extensive comorbidities, long-standing DM with difficult to control BGL.

3. If HbA1c is < 7.5-8%, post-prandial hyperglycemia contributes to high average BGL & is linked to macrovascular complications.

4. Some patients who are hospitalized do worse when their blood glucoses are tightly controlled. For critical patients keep BGL 140-180 using IV insulin.


Avatar
REFERENCES

1. Wilkinson, I. (2017). Oxford handbook of clinical medicine. Oxford: Oxford University Press.
2. Hannaman, R. A., Bullock, L., Hatchell, C. A., & Yoffe, M. (2016). Internal medicine review core curriculum, 2017-2018. CO Springs, CO: MedStudy.
3. Image: no reference available.

Ⓒ A. Manickam 2018

+ Home